Hepatology|多中心、回顾性研究比较TACE与TACE联合TKI和ICI作为不可切除肝细胞癌的转化治疗方案(GUIDANCE001)
DOI: 10.12449/JCH2502.gwqkjpwzjj1
Hepatology|Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
本文二维码
计量
- 文章访问数: 261
- HTML全文浏览量: 126
- PDF下载量: 27
- 被引次数: 0

PDF下载 ( 898 KB)
下载:
